SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1232395
NEW YORK, NY
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,659,836
-$958,209 QoQ
Shares Held
21,053
-18.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#748
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,659,836 | 21,053 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,618,045 | 25,960 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,293,850 | 26,836 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,279,607 | 20,537 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,270,174 | 20,476 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,357,532 | 21,040 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,572,414 | 17,023 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,427,208 | 17,023 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,167,948 | 17,023 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,246,934 | 17,023 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,381,220 | 17,050 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,239,057 | 16,534 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,281,982 | 16,634 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,361,454 | 16,409 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,414,722 | 16,479 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,012,086 | 16,406 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,024,562 | 16,576 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $997,333 | 16,776 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,292,748 | 17,804 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,287,056 | 18,426 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,273,910 | 18,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,211,812 | 18,750 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,357,516 | 23,301 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,554,158 | 24,595 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,004,825 | 26,057 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,980,915 | 26,497 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||